糖尿病母亲胎儿的脑发育:病例对照MR成像研究
前瞻性纳入26例糖尿病单胎孕妇与26例健康对照,于孕34至38周行3T胎儿脑多模态MR成像(1H-MRS、DWI、结构MRI),评估可行性与代谢物比值、ADC及脑体积。糖尿病组仅Cho/Cr比值略低于对照(0.46 vs 0.53,P=0.04),NAA/Cho、NAA/Cr、各区域ADC及大脑体积均无显著差异。作者认为3T多模态胎儿脑MR成像可行,并呼吁进一步研究母体糖尿病对胎儿脑代谢的影响。
要点
- 孕34至38周糖尿病母亲胎儿脑NAA/Cho、NAA/Cr及前白质、后白质、深灰质ADC与大脑体积与健康对照无显著差异。
- 仅Cho/Cr比值在糖尿病组略低于对照(0.46 vs 0.53,P=0.04)。
- 1H-MRS、DWI、结构MRI可用于后处理的数据分别来自79%、71%、46%的孕妇。
核心结论
- 在3T下对糖尿病孕妇行胎儿脑多模态MR成像可行;糖尿病组仅Cho/Cr比值略低于对照,其余代谢物比值、ADC及大脑体积与对照无显著差异;作者认为有必要进一步研究母体糖尿病中的胎儿脑代谢。
研究设计与样本
- 前瞻性病例对照研究,纳入糖尿病单胎孕妇26例与健康对照26例,于孕34至38周行3T胎儿脑MR成像,包括1H-MRS、DWI和结构MRI;1H-MRS、DWI、结构MRI获得可后处理数据的比例分别为79%、71%、46%。
关键影像表现/征象
- 糖尿病组胎儿脑NAA/Cho为1.74(0.79),对照组为1.79(0.64),P=0.81。
- 糖尿病组胎儿脑NAA/Cr为0.78(0.28),对照组为0.94(0.36),P=0.12。
- 糖尿病组胎儿脑Cho/Cr为0.46(0.11),对照组为0.53(0.10),P=0.04,糖尿病组略低。
- 前白质ADC糖尿病组1.16(0.12) vs 对照组1.16(0.08),P=0.96;后白质ADC糖尿病组1.54(0.16) vs 对照组1.59(0.20),P=0.56;深灰质ADC糖尿病组1.49(0.23) vs 对照组1.52(0.23),P=0.89。
- 大脑体积糖尿病组243.0 mL(22.7 mL) vs 对照组253.8 mL(31.6 mL),P=0.38。
诊断标准与关键数值
- NAA/Cho、NAA/Cr、Cho/Cr为1H-MRS代谢物比值,NAA/Cho与NAA/Cr在糖尿病组与对照组间无显著差异,Cho/Cr糖尿病组略低于对照组。
- 前白质、后白质、深灰质ADC(单位未在原文注明)在糖尿病组与对照组间均无显著差异。
- 大脑体积在糖尿病组与对照组间无显著差异。
临床应用与阅片要点
- 孕34至38周3T胎儿脑1H-MRS、DWI及结构MRI可用于评估胎儿脑代谢、微结构及宏观结构。
- 本研究中1H-MRS、DWI、结构MRI获得可后处理数据的比例分别为79%、71%、46%。
局限性
- 1H-MRS、DWI、结构MRI获得可后处理数据的比例分别为79%、71%、46%,结构MRI可后处理数据比例较低。
- 作者结论认为有必要进一步研究母体糖尿病中的胎儿脑代谢。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Offspring exposed to maternal diabetes are at increased risk of neurocognitive impairment, but its origins are unknown. With MR imaging, we investigated the feasibility of comprehensive assessment of brain metabolism (1H-MRS), microstructure (DWI), and macrostructure (structural MRI) in third-trimester fetuses in women with diabetes and determined normal ranges for the MR imaging parameters measured.
MATERIALS AND METHODS: Women with singleton pregnancies with diabetes (n = 26) and healthy controls (n = 26) were recruited prospectively for MR imaging studies between 34 and 38 weeks' gestation.
RESULTS: Data suitable for postprocessing were obtained from 79%, 71%, and 46% of women for 1H-MRS, DWI, and structural MRI, respectively. There was no difference in the NAA/Cho and NAA/Cr ratios (mean [SD]) in the fetal brain in women with diabetes compared with controls (1.74 [0.79] versus 1.79 [0.64], P = .81; and 0.78 [0.28] versus 0.94 [0.36], P = .12, respectively), but the Cho/Cr ratio was marginally lower (0.46 [0.11] versus 0.53 [0.10], P = .04). There was no difference in mean [SD] anterior white, posterior white, and deep gray matter ADC between patients and controls (1.16 [0.12] versus 1.16 [0.08], P = .96; 1.54 [0.16] versus 1.59 [0.20], P = .56; and 1.49 [0.23] versus 1.52 [0.23], P = .89, respectively) or volume of the cerebrum (243.0 mL [22.7 mL] versus 253.8 mL [31.6 mL], P = .38).
CONCLUSIONS: Acquiring multimodal MR imaging of the fetal brain at 3T from pregnant women with diabetes is feasible. Further study of fetal brain metabolism in maternal diabetes is warranted.
引用
- Denison FC, Macnaught G, Semple SIK, et al. Brain Development in Fetuses of Mothers with Diabetes: A Case-Control MR Imaging Study. AJNR Am J Neuroradiol. 2017. PMID: 28302607. doi:10.3174/ajnr.A5118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。